Questions discussed in this category
Will you recommend this as a first-line agent? Will you use this as monotherapy or only in combination with other agents like duloxetine?
Will you try the sublingual formulation in a patient who has failed the oral formulation, or vice versa?
What tools do you track to assess progress toward these goals?
When do you consider referral for neurocognitive assessment?
How do you differentiate symptoms related to centralized pain syndrome from possible cognitive dysfunction?
270922710319360271162725227093241661333416406
Papers discussed in this category
Arthritis and rheumatism, 2010-05
Ann Clin Transl Neurol, 2020 Jul 06
Lupus, 2023 Apr 10
Lupus Sci Med, 2022 Jan
Arthritis and rheumatism, 1994-01
Pain medicine (Malden, Mass.), 2025 Jul 08
Arthritis care & research, 2023 Jul 04
Annals of medicine, 2011 Jul 19